The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …

Antiplatelet drugs, such as aspirin, P2Y12 antagonists, and glycoprotein (GP) IIb/IIIa
inhibitors, have proved to be successful in reducing the morbidity and mortality associated …

Microvesicles (MVs) circulating in the blood are small vesicles (100–1,000 nm in diameter)
derived from membrane blebs of cells such as activated platelets, endothelial cells, and …

C-reactive protein (CRP) is a member of the pentraxin superfamily that is widely recognized
as a marker of inflammatory reactions and cardiovascular risk in humans. Recently, a …

C-reactive protein (CRP) is a member of the highly conserved pentraxin superfamily of
proteins and is often used in clinical practice as a marker of infection and inflammation …

Although the role of platelets as central mediators of hemostasis and thrombosis has been
the primary focus of research into platelet biology for more than a century, over the last …

C-reactive protein (CRP) is an evolutionary highly conserved member of the pentraxin
superfamily of proteins. CRP is widely used as a marker of inflammation, infection and for …

C-reactive protein (CRP) is the prototypic acute-phase reactant that has long been
recognized almost exclusively as a marker of inflammation and predictor of cardiovascular …

PI3KC2α is a broadly expressed lipid kinase with critical functions during embryonic
development but poorly defined roles in adult physiology. Here we utilize multiple mouse …

Background Nafamostat mesylate is a potent in vitro antiviral agent that inhibits the host
transmembrane protease serine 2 enzyme used by severe acute respiratory syndrome …